nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP1A2—chronic obstructive pulmonary disease	0.436	1	CbGaD
Rimonabant—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0443	0.11	CbGbCtD
Rimonabant—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0443	0.11	CbGbCtD
Rimonabant—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0418	0.104	CbGbCtD
Rimonabant—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0405	0.101	CbGbCtD
Rimonabant—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0405	0.101	CbGbCtD
Rimonabant—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0361	0.0899	CbGbCtD
Rimonabant—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.034	0.0846	CbGbCtD
Rimonabant—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0336	0.0836	CbGbCtD
Rimonabant—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.023	0.0571	CbGbCtD
Rimonabant—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0219	0.0545	CbGbCtD
Rimonabant—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0195	0.0486	CbGbCtD
Rimonabant—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0115	0.0285	CbGbCtD
Rimonabant—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0108	0.0269	CbGbCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.000734	0.00612	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000728	0.00607	CcSEcCtD
Rimonabant—Hypoglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.000708	0.0059	CcSEcCtD
Rimonabant—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000704	0.00587	CcSEcCtD
Rimonabant—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.000695	0.00579	CcSEcCtD
Rimonabant—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000688	0.00573	CcSEcCtD
Rimonabant—Irritability—Montelukast—chronic obstructive pulmonary disease	0.000684	0.0057	CcSEcCtD
Rimonabant—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00549	CcSEcCtD
Rimonabant—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.00549	CcSEcCtD
Rimonabant—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.000659	0.00549	CcSEcCtD
Rimonabant—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000656	0.00546	CcSEcCtD
Rimonabant—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000655	0.00545	CcSEcCtD
Rimonabant—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.000645	0.00538	CcSEcCtD
Rimonabant—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000641	0.00534	CcSEcCtD
Rimonabant—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00527	CcSEcCtD
Rimonabant—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00527	CcSEcCtD
Rimonabant—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00518	CcSEcCtD
Rimonabant—Influenza—Montelukast—chronic obstructive pulmonary disease	0.000619	0.00516	CcSEcCtD
Rimonabant—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.000616	0.00514	CcSEcCtD
Rimonabant—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000616	0.00513	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000612	0.0051	CcSEcCtD
Rimonabant—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000611	0.00509	CcSEcCtD
Rimonabant—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00498	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000588	0.0049	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000588	0.0049	CcSEcCtD
Rimonabant—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000579	0.00483	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000576	0.0048	CcSEcCtD
Rimonabant—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.000569	0.00474	CcSEcCtD
Rimonabant—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.00473	CcSEcCtD
Rimonabant—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.000566	0.00471	CcSEcCtD
Rimonabant—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000565	0.00471	CcSEcCtD
Rimonabant—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000562	0.00469	CcSEcCtD
Rimonabant—Delusion—Prednisone—chronic obstructive pulmonary disease	0.000561	0.00467	CcSEcCtD
Rimonabant—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00056	0.00467	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00462	CcSEcCtD
Rimonabant—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.000552	0.0046	CcSEcCtD
Rimonabant—Infestation—Montelukast—chronic obstructive pulmonary disease	0.000552	0.0046	CcSEcCtD
Rimonabant—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00055	0.00458	CcSEcCtD
Rimonabant—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.000546	0.00455	CcSEcCtD
Rimonabant—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.000546	0.00455	CcSEcCtD
Rimonabant—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000543	0.00452	CcSEcCtD
Rimonabant—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00441	CcSEcCtD
Rimonabant—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00441	CcSEcCtD
Rimonabant—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00432	CcSEcCtD
Rimonabant—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000508	0.00424	CcSEcCtD
Rimonabant—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000502	0.00418	CcSEcCtD
Rimonabant—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00416	CcSEcCtD
Rimonabant—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000497	0.00414	CcSEcCtD
Rimonabant—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000497	0.00414	CcSEcCtD
Rimonabant—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00411	CcSEcCtD
Rimonabant—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000493	0.00411	CcSEcCtD
Rimonabant—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000491	0.00409	CcSEcCtD
Rimonabant—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000487	0.00406	CcSEcCtD
Rimonabant—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000485	0.00404	CcSEcCtD
Rimonabant—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00396	CcSEcCtD
Rimonabant—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00391	CcSEcCtD
Rimonabant—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000469	0.00391	CcSEcCtD
Rimonabant—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000469	0.0039	CcSEcCtD
Rimonabant—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000463	0.00386	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000462	0.00385	CcSEcCtD
Rimonabant—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000456	0.0038	CcSEcCtD
Rimonabant—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.0038	CcSEcCtD
Rimonabant—Contusion—Prednisone—chronic obstructive pulmonary disease	0.000455	0.00379	CcSEcCtD
Rimonabant—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000455	0.00379	CcSEcCtD
Rimonabant—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000451	0.00375	CcSEcCtD
Rimonabant—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00045	0.00375	CcSEcCtD
Rimonabant—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000447	0.00372	CcSEcCtD
Rimonabant—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000447	0.00372	CcSEcCtD
Rimonabant—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000446	0.00372	CcSEcCtD
Rimonabant—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000444	0.0037	CcSEcCtD
Rimonabant—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000444	0.0037	CcSEcCtD
Rimonabant—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.0037	CcSEcCtD
Rimonabant—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000443	0.00369	CcSEcCtD
Rimonabant—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00367	CcSEcCtD
Rimonabant—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00367	CcSEcCtD
Rimonabant—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000437	0.00364	CcSEcCtD
Rimonabant—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00362	CcSEcCtD
Rimonabant—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00361	CcSEcCtD
Rimonabant—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000433	0.00361	CcSEcCtD
Rimonabant—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.0036	CcSEcCtD
Rimonabant—Tension—Formoterol—chronic obstructive pulmonary disease	0.000432	0.0036	CcSEcCtD
Rimonabant—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.00359	CcSEcCtD
Rimonabant—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000428	0.00357	CcSEcCtD
Rimonabant—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000428	0.00357	CcSEcCtD
Rimonabant—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000427	0.00356	CcSEcCtD
Rimonabant—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00353	CcSEcCtD
Rimonabant—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00353	CcSEcCtD
Rimonabant—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000421	0.00351	CcSEcCtD
Rimonabant—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.00349	CcSEcCtD
Rimonabant—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.00347	CcSEcCtD
Rimonabant—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000415	0.00346	CcSEcCtD
Rimonabant—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00344	CcSEcCtD
Rimonabant—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00344	CcSEcCtD
Rimonabant—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000411	0.00342	CcSEcCtD
Rimonabant—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.0034	CcSEcCtD
Rimonabant—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000404	0.00337	CcSEcCtD
Rimonabant—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000404	0.00337	CcSEcCtD
Rimonabant—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000403	0.00336	CcSEcCtD
Rimonabant—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00333	CcSEcCtD
Rimonabant—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.00333	CcSEcCtD
Rimonabant—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00331	CcSEcCtD
Rimonabant—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00325	CcSEcCtD
Rimonabant—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.00322	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000385	0.00321	CcSEcCtD
Rimonabant—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000375	0.00313	CcSEcCtD
Rimonabant—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000374	0.00312	CcSEcCtD
Rimonabant—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00311	CcSEcCtD
Rimonabant—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00311	CcSEcCtD
Rimonabant—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.00311	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.0031	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000373	0.0031	CcSEcCtD
Rimonabant—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00306	CcSEcCtD
Rimonabant—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00306	CcSEcCtD
Rimonabant—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000366	0.00305	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000365	0.00304	CcSEcCtD
Rimonabant—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.00304	CcSEcCtD
Rimonabant—Infection—Formoterol—chronic obstructive pulmonary disease	0.000357	0.00298	CcSEcCtD
Rimonabant—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.00298	CcSEcCtD
Rimonabant—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00294	CcSEcCtD
Rimonabant—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000353	0.00294	CcSEcCtD
Rimonabant—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.00294	CcSEcCtD
Rimonabant—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.00294	CcSEcCtD
Rimonabant—Infection—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00292	CcSEcCtD
Rimonabant—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00291	CcSEcCtD
Rimonabant—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00291	CcSEcCtD
Rimonabant—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00289	CcSEcCtD
Rimonabant—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00288	CcSEcCtD
Rimonabant—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00285	CcSEcCtD
Rimonabant—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.00281	CcSEcCtD
Rimonabant—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00279	CcSEcCtD
Rimonabant—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.00277	CcSEcCtD
Rimonabant—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00275	CcSEcCtD
Rimonabant—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000328	0.00274	CcSEcCtD
Rimonabant—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000325	0.00271	CcSEcCtD
Rimonabant—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000325	0.00271	CcSEcCtD
Rimonabant—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000324	0.0027	CcSEcCtD
Rimonabant—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000323	0.00269	CcSEcCtD
Rimonabant—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000319	0.00265	CcSEcCtD
Rimonabant—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00264	CcSEcCtD
Rimonabant—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00263	CcSEcCtD
Rimonabant—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000313	0.0026	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000311	0.00259	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000311	0.00259	CcSEcCtD
Rimonabant—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00031	0.00258	CcSEcCtD
Rimonabant—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00031	0.00258	CcSEcCtD
Rimonabant—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000307	0.00256	CcSEcCtD
Rimonabant—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000307	0.00255	CcSEcCtD
Rimonabant—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00254	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00253	CcSEcCtD
Rimonabant—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000304	0.00253	CcSEcCtD
Rimonabant—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0003	0.0025	CcSEcCtD
Rimonabant—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00248	CcSEcCtD
Rimonabant—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000298	0.00248	CcSEcCtD
Rimonabant—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.00247	CcSEcCtD
Rimonabant—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00246	CcSEcCtD
Rimonabant—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000295	0.00246	CcSEcCtD
Rimonabant—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000294	0.00245	CcSEcCtD
Rimonabant—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.00245	CcSEcCtD
Rimonabant—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000294	0.00245	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00244	CcSEcCtD
Rimonabant—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000293	0.00244	CcSEcCtD
Rimonabant—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000288	0.0024	CcSEcCtD
Rimonabant—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00237	CcSEcCtD
Rimonabant—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00237	CcSEcCtD
Rimonabant—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00236	CcSEcCtD
Rimonabant—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00234	CcSEcCtD
Rimonabant—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00234	CcSEcCtD
Rimonabant—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000281	0.00234	CcSEcCtD
Rimonabant—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000281	0.00234	CcSEcCtD
Rimonabant—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.00233	CcSEcCtD
Rimonabant—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000278	0.00232	CcSEcCtD
Rimonabant—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000278	0.00231	CcSEcCtD
Rimonabant—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000275	0.00229	CcSEcCtD
Rimonabant—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00227	CcSEcCtD
Rimonabant—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00224	CcSEcCtD
Rimonabant—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00221	CcSEcCtD
Rimonabant—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00215	CcSEcCtD
Rimonabant—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00215	CcSEcCtD
Rimonabant—CNR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000255	0.00598	CbGpPWpGaD
Rimonabant—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00212	CcSEcCtD
Rimonabant—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00212	CcSEcCtD
Rimonabant—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000254	0.00594	CbGpPWpGaD
Rimonabant—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000253	0.00211	CcSEcCtD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00025	0.00585	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000249	0.00584	CbGpPWpGaD
Rimonabant—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00208	CcSEcCtD
Rimonabant—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00205	CcSEcCtD
Rimonabant—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00205	CcSEcCtD
Rimonabant—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00203	CcSEcCtD
Rimonabant—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000243	0.0057	CbGpPWpGaD
Rimonabant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000241	0.00565	CbGpPWpGaD
Rimonabant—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000241	0.00201	CcSEcCtD
Rimonabant—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.002	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000238	0.00557	CbGpPWpGaD
Rimonabant—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000238	0.00198	CcSEcCtD
Rimonabant—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000238	0.00198	CcSEcCtD
Rimonabant—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.00548	CbGpPWpGaD
Rimonabant—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000233	0.00194	CcSEcCtD
Rimonabant—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00194	CcSEcCtD
Rimonabant—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00537	CbGpPWpGaD
Rimonabant—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.00191	CcSEcCtD
Rimonabant—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000229	0.00191	CcSEcCtD
Rimonabant—Rash—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00189	CcSEcCtD
Rimonabant—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00189	CcSEcCtD
Rimonabant—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00189	CcSEcCtD
Rimonabant—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00189	CcSEcCtD
Rimonabant—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00188	CcSEcCtD
Rimonabant—Headache—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00188	CcSEcCtD
Rimonabant—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00187	CcSEcCtD
Rimonabant—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00187	CcSEcCtD
Rimonabant—Rash—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00185	CcSEcCtD
Rimonabant—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00185	CcSEcCtD
Rimonabant—Depression—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00184	CcSEcCtD
Rimonabant—Headache—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00184	CcSEcCtD
Rimonabant—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00022	0.00516	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00022	0.00514	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000219	0.00512	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000218	0.00511	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000216	0.00506	CbGpPWpGaD
Rimonabant—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.0018	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000215	0.00502	CbGpPWpGaD
Rimonabant—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00178	CcSEcCtD
Rimonabant—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00178	CcSEcCtD
Rimonabant—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00178	CcSEcCtD
Rimonabant—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00178	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000213	0.00499	CbGpPWpGaD
Rimonabant—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00177	CcSEcCtD
Rimonabant—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00495	CbGpPWpGaD
Rimonabant—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00174	CcSEcCtD
Rimonabant—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000207	0.00172	CcSEcCtD
Rimonabant—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000203	0.00475	CbGpPWpGaD
Rimonabant—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00168	CcSEcCtD
Rimonabant—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00471	CbGpPWpGaD
Rimonabant—CNR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.0002	0.00469	CbGpPWpGaD
Rimonabant—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000198	0.00165	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000196	0.00459	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00163	CcSEcCtD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000193	0.00451	CbGpPWpGaD
Rimonabant—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00451	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000192	0.00449	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.00019	0.00446	CbGpPWpGaD
Rimonabant—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00157	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000187	0.00437	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000182	0.00425	CbGpPWpGaD
Rimonabant—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00151	CcSEcCtD
Rimonabant—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000177	0.00415	CbGpPWpGaD
Rimonabant—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000177	0.00414	CbGpPWpGaD
Rimonabant—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.00147	CcSEcCtD
Rimonabant—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.00146	CcSEcCtD
Rimonabant—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00145	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000174	0.00408	CbGpPWpGaD
Rimonabant—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00144	CcSEcCtD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000172	0.00402	CbGpPWpGaD
Rimonabant—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00399	CbGpPWpGaD
Rimonabant—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00398	CbGpPWpGaD
Rimonabant—CNR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00017	0.00398	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00017	0.00397	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000169	0.00395	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000167	0.00391	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000167	0.0039	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00373	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000158	0.0037	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000157	0.00367	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00362	CbGpPWpGaD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00359	CbGpPWpGaD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00357	CbGpPWpGaD
Rimonabant—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.00354	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000151	0.00353	CbGpPWpGaD
Rimonabant—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00125	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000149	0.0035	CbGpPWpGaD
Rimonabant—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00123	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00122	CcSEcCtD
Rimonabant—Infection—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00117	CcSEcCtD
Rimonabant—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00116	CcSEcCtD
Rimonabant—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00115	CcSEcCtD
Rimonabant—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00114	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000137	0.0032	CbGpPWpGaD
Rimonabant—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000135	0.00316	CbGpPWpGaD
Rimonabant—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00112	CcSEcCtD
Rimonabant—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000134	0.00314	CbGpPWpGaD
Rimonabant—CNR1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000133	0.00312	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000132	0.0031	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000131	0.00306	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000129	0.00302	CbGpPWpGaD
Rimonabant—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00107	CcSEcCtD
Rimonabant—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00107	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000128	0.00299	CbGpPWpGaD
Rimonabant—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00106	CcSEcCtD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00293	CbGpPWpGaD
Rimonabant—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000125	0.00293	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00291	CbGpPWpGaD
Rimonabant—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00103	CcSEcCtD
Rimonabant—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Rimonabant—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00102	CcSEcCtD
Rimonabant—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00102	CcSEcCtD
Rimonabant—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00102	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00012	0.00282	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00276	CbGpPWpGaD
Rimonabant—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00276	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00276	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000116	0.00272	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000964	CcSEcCtD
Rimonabant—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000964	CcSEcCtD
Rimonabant—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000115	0.00268	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00263	CbGpPWpGaD
Rimonabant—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000932	CcSEcCtD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00261	CbGpPWpGaD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.0026	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00258	CbGpPWpGaD
Rimonabant—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00257	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000109	0.00256	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000108	0.00252	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000106	0.00248	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000103	0.00242	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000103	0.00241	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000103	0.00241	CbGpPWpGaD
Rimonabant—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000846	CcSEcCtD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00237	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.0001	0.00235	CbGpPWpGaD
Rimonabant—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000834	CcSEcCtD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.98e-05	0.00234	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.77e-05	0.00229	CbGpPWpGaD
Rimonabant—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.000807	CcSEcCtD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.52e-05	0.00223	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.45e-05	0.00221	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.41e-05	0.0022	CbGpPWpGaD
Rimonabant—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.39e-05	0.0022	CbGpPWpGaD
Rimonabant—Dizziness—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.00078	CcSEcCtD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.11e-05	0.00213	CbGpPWpGaD
Rimonabant—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	9.09e-05	0.00213	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.03e-05	0.00211	CbGpPWpGaD
Rimonabant—Vomiting—Prednisone—chronic obstructive pulmonary disease	9e-05	0.00075	CcSEcCtD
Rimonabant—Rash—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000744	CcSEcCtD
Rimonabant—Dermatitis—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000743	CcSEcCtD
Rimonabant—Headache—Prednisone—chronic obstructive pulmonary disease	8.87e-05	0.000739	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.58e-05	0.00201	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.55e-05	0.002	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.44e-05	0.00198	CbGpPWpGaD
Rimonabant—Nausea—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.0007	CcSEcCtD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8.2e-05	0.00192	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.08e-05	0.00189	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.08e-05	0.00189	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	8.04e-05	0.00188	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.01e-05	0.00188	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.94e-05	0.00186	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.92e-05	0.00185	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.85e-05	0.00184	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.72e-05	0.00181	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.67e-05	0.0018	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.53e-05	0.00176	CbGpPWpGaD
Rimonabant—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	7.39e-05	0.00173	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.39e-05	0.00173	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.35e-05	0.00172	CbGpPWpGaD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.25e-05	0.0017	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	7e-05	0.00164	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.79e-05	0.00159	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.71e-05	0.00157	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.71e-05	0.00157	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.66e-05	0.00156	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.6e-05	0.00155	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.57e-05	0.00154	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	6.51e-05	0.00152	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.51e-05	0.00152	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.46e-05	0.00151	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.96e-05	0.00139	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.91e-05	0.00138	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.82e-05	0.00136	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.77e-05	0.00135	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.58e-05	0.00131	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.55e-05	0.0013	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	5.52e-05	0.00129	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.51e-05	0.00129	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.49e-05	0.00129	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.48e-05	0.00128	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.43e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.00124	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.25e-05	0.00123	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.24e-05	0.00123	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.18e-05	0.00121	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.1e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.07e-05	0.00119	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	5.06e-05	0.00118	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.06e-05	0.00118	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.05e-05	0.00118	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.03e-05	0.00118	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.99e-05	0.00117	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.96e-05	0.00116	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.96e-05	0.00116	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.84e-05	0.00113	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.8e-05	0.00112	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.77e-05	0.00112	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.77e-05	0.00112	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.73e-05	0.00111	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.73e-05	0.00111	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.73e-05	0.00111	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.71e-05	0.0011	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.69e-05	0.0011	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.64e-05	0.00109	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.56e-05	0.00107	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.53e-05	0.00106	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.35e-05	0.00102	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.32e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.00101	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.26e-05	0.000998	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.14e-05	0.00097	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.12e-05	0.000964	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.1e-05	0.00096	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.04e-05	0.000946	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.96e-05	0.000928	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.89e-05	0.000911	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.86e-05	0.000904	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.86e-05	0.000903	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.68e-05	0.000862	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.68e-05	0.000862	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.63e-05	0.00085	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.58e-05	0.000838	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.52e-05	0.000823	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.34e-05	0.000781	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	3.3e-05	0.000772	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.29e-05	0.00077	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.16e-05	0.000741	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.00073	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.12e-05	0.00073	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.03e-05	0.000709	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.97e-05	0.000694	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.89e-05	0.000677	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.82e-05	0.000661	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.76e-05	0.000646	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.75e-05	0.000644	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.58e-05	0.000604	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.56e-05	0.000598	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.55e-05	0.000596	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.54e-05	0.000593	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.53e-05	0.000593	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.51e-05	0.000587	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.49e-05	0.000582	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.45e-05	0.000573	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.35e-05	0.00055	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.33e-05	0.000546	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.33e-05	0.000545	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.33e-05	0.000544	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.31e-05	0.000541	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.28e-05	0.000534	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.21e-05	0.000518	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.18e-05	0.000511	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.13e-05	0.000497	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.99e-05	0.000465	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.98e-05	0.000462	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.91e-05	0.000448	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.000431	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.83e-05	0.000427	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.79e-05	0.000419	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.75e-05	0.00041	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.69e-05	0.000395	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.64e-05	0.000384	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.000368	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000357	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.5e-05	0.000352	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.38e-05	0.000322	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.37e-05	0.000321	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000318	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000317	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.34e-05	0.000314	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.25e-05	0.000293	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.24e-05	0.000289	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000287	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.16e-05	0.000272	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.15e-05	0.000269	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.14e-05	0.000267	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000264	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.07e-05	0.00025	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.05e-05	0.000245	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.5e-06	0.000222	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.42e-06	0.00022	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.37e-06	0.000219	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.29e-06	0.000217	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.96e-06	0.00021	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.86e-06	0.000207	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.73e-06	0.000204	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.65e-06	0.000203	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.27e-06	0.000194	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.2e-06	0.000192	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	8.08e-06	0.000189	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.05e-06	0.000188	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.94e-06	0.000186	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.45e-06	0.000174	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.39e-06	0.000173	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.01e-06	0.000164	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.21e-06	0.000145	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.12e-06	0.000143	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.71e-06	0.000134	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.62e-06	0.000132	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	5.58e-06	0.000131	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.41e-06	0.000127	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.38e-06	0.000126	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.33e-06	0.000125	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.76e-06	0.000112	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.56e-06	0.000107	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.68e-06	8.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.52e-06	8.23e-05	CbGpPWpGaD
